Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Yestar Healthcare Holdings Company Limited
  6. Summary
    2393   KYG9843W1125

YESTAR HEALTHCARE HOLDINGS COMPANY LIMITED

(2393)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Hong Kong Stock Exchange
01/24/2022 01/25/2022 01/26/2022 01/27/2022 01/28/2022 Date
1.14 1.12 1.14 1.13 1.1 Last
82500 125000 107500 57500 57500 Volume
-0.87% -1.75% +1.79% -0.88% -2.65% Change
Estimated financial data (e)
Sales 2021 4 875 M 767 M 767 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 13,8x
Yield 2021 -
Sales 2022 5 335 M 839 M 839 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 12,2x
Yield 2022 -
Capitalization 2 565 M 329 M 403 M
Capi. / Sales 2021 0,53x
Capi. / Sales 2022 0,48x
Nbr of Employees 1 054
Free-Float 28,3%
More Financials
Company
Yestar Healthcare Holdings Company Limited., formerly Yestar International Holdings Company Limited is an investment holding company principally engaged in the manufacture and sale of medical imaging products. The Company operates its business through two segments. The Imaging Printing Products segment is engaged in the manufacture and sale of color photographic paper, industrial Non Destructive Testing (NDT) x-ray... 
More about the company
Ratings of Yestar Healthcare Holdings Company Limited
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about YESTAR HEALTHCARE HOLDINGS COMPANY LIMITED
2021Yestar Healthcare Holdings Company Limited Announces Management Changes
CI
2021YESTAR HEALTHCARE : List of Directors and their Roles and Functions
PU
2021Yestar Healthcare Holdings Company Limited Announces Board Changes
CI
2021YESTAR HEALTHCARE : Extends Deadline for Bondholders to Accept Debt Restructuring Offer
MT
2021Yestar Healthcare Holdings Company Limited Update on Offshore Debt Restructuring in the..
CI
2021YESTAR HEALTHCARE : Suspends, Delists $200 Million of 6.9% Bonds Due Next Week amid Debt R..
MT
2021Yestar Healthcare Holdings Company Limited Reports Earnings Results for the Half Year E..
CI
2021YESTAR HEALTHCARE : Positive profit alert
PU
2021Yestar Healthcare Holdings Company Limited Provides Earnings Guidance for the Six Month..
CI
2021Yestar Healthcare Holdings Company Limited Proposes Offshore Debt Restructuring in the ..
CI
2021Yestar Healthcare Holdings Company Limited Appoints Li Bin as an Executive Director
CI
2021Yestar Healthcare Holdings Company Limited commences an Equity Buyback Plan for 235,094..
CI
2021Yestar Healthcare Holdings Company Limited Announces Board Changes
CI
2021Yestar Healthcare Holdings Company Limited's Equity Buyback announced on May 22, 2020, ..
CI
2021YESTAR HEALTHCARE : Next Day Disclosure Returns
PU
More news
News in other languages on YESTAR HEALTHCARE HOLDINGS COMPANY LIMITED
2021Yestar Healthcare Holdings Company Limited annonce des changements de direction
2021Yestar Healthcare Holdings Company Limited annonce des changements au sein de son conse..
2021Yestar suspend et retire de la cote 200 millions de dollars d'obligations à 6,9 % échéa..
2021Yestar Healthcare Holdings Company Limited fournit des prévisions de bénéfices pour les..
2020Yestar Healthcare Holdings Company Limited fournit des prévisions de bénéfices pour les..
More news
Chart YESTAR HEALTHCARE HOLDINGS COMPANY LIMITED
Duration : Period :
Yestar Healthcare Holdings Company Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends YESTAR HEALTHCARE HOLDINGS COMPANY LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Last Close Price 1,10 CNY
Average target price 0,86 CNY
Spread / Average Target -21,6%
EPS Revisions
Managers and Directors
James Hartono Chairman & Chief Executive Officer
Hong Wang Chief Financial Officer & Executive Director
Chung Man Chan Chief Operating Officer
Yi Ming Hu Independent Non-Executive Director
Liky Sutikno Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
YESTAR HEALTHCARE HOLDINGS COMPANY LIMITED-4.35%338
ABBOTT LABORATORIES-14.42%206 551
MEDTRONIC PLC-0.26%138 731
BECTON, DICKINSON AND COMPANY0.96%71 600
HOYA CORPORATION-18.59%44 518
BAXTER INTERNATIONAL INC.-1.41%42 374